Assessment of Cytomegalovirus-Speci fi c Cell-Mediated Immunity for the Prediction of Cytomegalovirus Disease in High-Risk Solid-Organ Transplant Recipients : A Multicenter Cohort Study

Oriol Manuel, Shahid Husain, Deepali Kumar, Carlos Zayas, Steve Mawhorter, Marilyn E. Levi, Jayant Kalpoe, Luiz Lisboa, Leticia Ely, Daniel R. Kaul, Brian S. Schwartz, Michele I. Morris, Michael G. Ison, Belinda Yen-Lieberman, Anthony Sebastian, Maha Assi, and Atul Humar Infectious Diseases Service and Transplantation Center, University Hospital and University of Lausanne, Switzerland; Department of Medicine, Division of Infectious Diseases, University Health Network, University of Toronto, and Alberta Transplant Institute, University of Alberta, Edmonton, Canada; Transplant Services, Piedmont Hospital, Atlanta, Georgia, Department of Infectious Diseases, Cleveland Clinic, Ohio, Division of Infectious Diseases, University of Colorado, Aurora; Department of Medical Microbiology, Leiden University Medical Center, The Netherlands; Department of Internal Medicine, Division of Infectious Disease, University of Michigan Medical School, Ann Arbor, Division of Infectious Diseases, University of California, San Francisco, Division of Infectious Diseases, University of Miami Miller School of Medicine, Florida, Divisions of Infectious Diseases and Organ Transplantation, Northwestern University Feinberg School of Medicine, Chicago, Illinois, Section of Immunopathology, Pathology and Laboratory Medicine Institute, Cleveland Clinic, Ohio, Abdominal Transplant Surgery Division, Oklahoma Transplant Center, University of Oklahoma Health Sciences Center, Oklahoma City, and Department of Infectious Disease, University of Kansas School of Medicine, Wichita